文献速递呼吸衰竭与机械通气重症综合管理与镇静镇痛

机械通气与2019冠状病毒病:临床特征、肺力学与死亡率的病例对照分析

Mechanical Ventilation and Coronavirus Disease 2019: A Case-Control Analysis of Clinical Characteristics, Lung Mechanics, and Mortality.
PubMed 文献 · Crit Care Explor · 2021-03-26
一句话结论COVID-19相关ARDS患者住院死亡率64%高于历史ARDS对照49%,肺力学与初始SOFA相似但进行性低氧,COVID-19感染、高龄、使用肌松剂和高SOFA为独立死亡危险因素。

该多中心病例对照研究纳入384例成人住院患者,比较COVID-19相关ARDS患者与大流行前ARDS对照的临床过程、呼吸机力学和结局。COVID-19组住院死亡率显著更高(64% vs 49%;p=0.007),尽管两组插管第1天通气功能和SOFA评分相似、研究期间肺顺应性相似,COVID-19组仍出现进行性低氧,且更高PEEP水平和更多肌松剂使用。多因素分析显示COVID-19感染(OR 1.939;p=0.021)、高龄(OR 1.042;p<0.001)、使用肌松剂(OR 3.366;p<0.001)和更高SOFA评分(OR 1.152;p=0.027)为全队列死亡的显著预测因素。

要点

  • COVID-19相关ARDS患者住院死亡率64%,显著高于大流行前ARDS对照49%(p=0.007)。
  • 两组插管第1天通气功能与SOFA评分相似、研究期间肺顺应性相似,但COVID-19组出现进行性低氧。
  • COVID-19组观察到更高PEEP水平和更多肌松剂使用。
  • 全队列多因素分析:COVID-19感染OR 1.939(p=0.021)、高龄OR 1.042(p<0.001)、肌松剂使用OR 3.366(p<0.001)、更高SOFA评分OR 1.152(p=0.027)为死亡独立预测因素。

适用人群与场景

  • 成人住院的COVID-19继发ARDS感染患者,与大流行前住院的ARDS患者(对照)比较。
  • 多中心、综合性三级医疗中心(美国密歇根州底特律)。

研究设计与关键结果

  • 比较性病例对照研究,纳入384例患者分析。
  • COVID-19相关ARDS组住院死亡率64% vs 对照49%(p=0.007)。
  • 两组插管第1天通气功能和SOFA评分相似,研究期间肺顺应性相似,但COVID-19组研究期间出现进行性低氧。
  • COVID-19组观察到更高PEEP水平和更多肌松剂使用。
  • 全队列单因素分析:住院死亡显著危险因素包括COVID-19感染(p=0.007)、高龄(p<0.001)、高SOFA评分(p=0.003)、使用血管升压药(p=0.039)、使用肌松剂(p<0.001)、第3天更高PEEP水平(p=0.027)、第7天更高PEEP水平(p<0.001)、第3天ARDS严重程度(p=0.008)、第7天ARDS严重程度(p<0.001)。
  • 全队列多因素分析:COVID-19感染(OR 1.939;p=0.021)、高龄(OR 1.042;p<0.001)、使用肌松剂(OR 3.366;p<0.001)、更高SOFA评分(OR 1.152;p=0.027)为死亡显著预测因素。

证据类型、等级与局限

  • 证据类型:比较性病例对照研究。
  • 局限:原文未报告局限性

对床旁实践的改变

  • 原文未据此给出推荐。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVES: To investigate the differences in clinical course, ventilator mechanics, and outcomes of patients with coronavirus disease 2019 secondary to acute respiratory distress syndrome infection compared with a historical cohort of acute respiratory distress syndrome.

DESIGN: Comparative case-control study.

SETTING: Multicenter, comprehensive tertiary healthcare facility in Detroit, MI.

PATIENTS/SUBJECTS: Adult patients hospitalized with coronavirus disease 2019 secondary to acute respiratory distress syndrome infection were compared with patients hospitalized with acute respiratory distress syndrome prior to the coronavirus disease 2019 pandemic (control).

INTERVENTIONS: None.

MEASUREMENTS AND MAIN RESULTS: We included 384 patients in the analysis. Inpatient mortality was significantly higher in patients with coronavirus disease 2019 secondary to acute respiratory distress syndrome infection compared with controls (64% vs 49%; p = 0.007). Despite both groups demonstrating similar ventilatory function and Sequential Organ Failure Assessment score on day 1 of intubation, with similar lung compliance throughout the study period, patients with coronavirus disease 2019 secondary to acute respiratory distress syndrome infection demonstrated progressive hypoxia compared with controls across the study period. Similarly, higher positive end-expiratory pressure levels and increased use of paralytics were observed in the patients with coronavirus disease 2019 secondary to acute respiratory distress syndrome infection group. On univariate analysis of the entire cohort, significant risk factors for inpatient mortality included coronavirus disease 2019 infection (p = 0.007), older age (p < 0.001), high Sequential Organ Failure Assessment score (p = 0.003), vasopressor use (p = 0.039), paralytic use (p < 0.001), higher positive end-expiratory pressure levels on day 3 (p = 0.027) and day 7 (p < 0.001), in addition to acute respiratory distress syndrome severity on both days 3 (p = 0.008) and 7 (p < 0.001). Multivariate analysis identified coronavirus disease 2019 infection (odds ratio, 1.939; p = 0.021), older age (odds ratio, 1.042; p < 0.001), paralytic use (odds ratio, 3.366; p < 0.001), and higher Sequential Organ Failure Assessment score (odds ratio, 1.152; p = 0.027) as significant predictors of mortality across the entire cohort.

CONCLUSIONS: Patients with coronavirus disease 2019 secondary to acute respiratory distress syndrome infection demonstrated higher mortality compared with control patients hospitalized with acute respiratory distress syndrome prior to the pandemic, with progressive hypoxia throughout the study period, despite similar lung mechanics and initial Sequential Organ Failure Assessment score. Coronavirus disease 2019 infection, older age, paralytic use, and higher Sequential Organ Failure Assessment scores were independent risk factors for 28-day mortality across the entire cohort.

来源:Crit Care Explor,查看原文。版权归原作者所有。

参考来源

  1. Abu Sayf A, Fadel R, Scott A, et al. Mechanical Ventilation and Coronavirus Disease 2019: A Case-Control Analysis of Clinical Characteristics, Lung Mechanics, and Mortality. Crit Care Explor. 2021. PMID: 33937864. doi:10.1097/CCE.0000000000000377

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。